Literature DB >> 381947

The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.

K Schrör.   

Abstract

The action of the dihydro prostacyclins, (6R)-PGI1 and (6S)-PGI1, was studied on the isolated guinea pig heart and bovine coronary artery strips. PGE2 and PGI2 were used as standards. In the isolated guinea pig heart (6S)-PGI1 decreased the coronary perfusion pressure (CPP), myocardial force of contraction (MFC) and oxygen consumption (QO2). (6R)-PGI1 did not produce a significant change in these parameters. The ED50 (50% o maximum coronary dilation) was approximately 20 times higher for (6S)-PGI1 than for PGI2 or PGE2. Treatment of the hearts with reserpine + tyramine abolished the (6S)-PGI1-induced decrease in MFC but not the decrease in the CPP. The same pattern of responses was seen with PGE2. Bovine coronary artery strips were contracted by both (6S)-PGI1 and (6R)-PGI1, the ED50 (50% of maximum increase in tension) being 5 and 10 times higher than that for PGE2. The (6S)-PGI1-induced contraction was preceeded by a small relaxation, which, however, was much less than that seen after PGI2. It is concluded that the hydration of the 5,6 double bound in the PGI2 molecule results in an almost complete loss of PGI2-like activity and generates PGE-like activity. The same biological activity of both dihydro prostacyclins in the isolated coronary artery strip but not in the intact coronary vascular bed leads to suggest that the sites of action in these systems are different.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381947     DOI: 10.1007/bf00507106

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.

Authors:  B J Whittle; N K Boughton-Smith; S Moncada; J R Vane
Journal:  J Pharm Pharmacol       Date:  1978-09       Impact factor: 3.765

2.  Prostacyclin: a potent coronary dilating agent in the rat isolated heart [proceedings].

Authors:  H B Link; R Rösen; K Schrör
Journal:  J Physiol       Date:  1978-11       Impact factor: 5.182

3.  Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart.

Authors:  E A de Deckere; D H Nugteren; F Ten Hoor
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

4.  Inhibition of human platelet aggregation by stable analogs of prostacyclin.

Authors:  G Togna; C GAndolfi; A Andreoni; A Fumagalli; C Passarotti; F Faustini; C Patrono
Journal:  Pharmacol Res Commun       Date:  1977-11

5.  Comparison of the effects of prostaglandins E 1, E 2 and F 2 alpha on the sympathetically stimulated rabbit heart.

Authors:  P Hedqvist; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1971-10

6.  [An improved method for simultaneous measurement of oxygen consumption and mechanical activity of isolated muscle preparations].

Authors:  W Klaus; R Krebs
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

7.  Prostaglandin D2 inhibits the aggregation of human platelets.

Authors:  J B Smith; M J Silver; C M Ingerman; J J Kocsis
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

8.  The chemical structure of prostaglandin X (prostacyclin).

Authors:  N Whittaker; S Bunting; J Salmon; S Moncada; J R Vane; R A Johnson; D R Morton; J H Kinner; R R Gorman; J C McGuire; F F Sun
Journal:  Prostaglandins       Date:  1976-12

9.  Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.

Authors:  K Schrör; S Moncada; F B Ubatuba; J R Vane
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

10.  Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-01
View more
  1 in total

1.  The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors:  K Schrör; H Darius; R Matzky; R Ohlendorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.